Literature DB >> 27413708

Assessing the shift of radiobiological metrics in lung radiotherapy plans using 2D gamma index.

Abdulhamid Chaikh1, Jacques Balosso1.   

Abstract

BACKGROUND: The purpose of this work is to investigate the 2D gamma (γ) maps to illustrate the change of radiobiological outcomes for lung radiotherapy plans and evaluate the correlation between tumor control probability (TCP), normal tissue complication probability (NTCP) with γ passing rates (γ-rates).
METHODS: Nine patients with lung cancer were used. The doses were calculated using Modified Batho method integrated with pencil beam convolution (MB-PBC) and anisotropic analytical algorithm (AAA) using the same beam arrangements and prescription dose. The TCP and NTCP were estimated, respectively, using equivalent uniform dose (EUD) model and Lyman-Kutcher-Burman (LKB) model. The correlation between ΔTCP or ΔNTCP with γ-rates, from 2%/2 and 3%/3 mm, were tested to explore the best correlation predicting the relevant γ criteria using Spearman's rank test (ρ). Wilcoxon paired test was used to calculate P value.
RESULTS: TCP value was significantly lower in the recalculated AAA plans as compared to MB plans. However, AAA predicted more NTCP on lung pneumonitis according to the LKB model and using relevant radiobiological parameters (n, m and TD50) for MB-PBC and AAA, with P=0.03. The data showed a weak correlation between radiobiological metrics with γ-rates or γ-mean, ρ<0.3.
CONCLUSIONS: AAA and MB yield different TCP values as well as NTCP for lung pneumonitis based on the LKB model parameters. Therefore, 2D γ-maps, generated with 2%/2 or 3%/3 mm, could illustrate visual information about the radiobiological changes. The information is useful to evaluate the clinical outcome of a radiotherapy treatment and to approve the treatment plan of the patient if the dose constraints are respected. On the other hand, the γ-maps tool can be used as quality assurance (QA) process to check the predicted TCP and NTCP from radiobiological models.

Entities:  

Keywords:  Tumor control probability (TCP); gamma; normal tissue complication probability (NTCP); radiotherapy

Year:  2016        PMID: 27413708      PMCID: PMC4931122          DOI: 10.21037/tlcr.2016.06.01

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN: 2218-6751


  27 in total

1.  LUNG CORRECTIONS IN COBALT 60 BEAM THERAPY.

Authors:  H F BATHO
Journal:  J Can Assoc Radiol       Date:  1964-06

2.  Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations.

Authors:  G J Kutcher; C Burman; L Brewster; M Goitein; R Mohan
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-05-15       Impact factor: 7.038

3.  Gamma histograms for radiotherapy plan evaluation.

Authors:  Emiliano Spezi; D Geraint Lewis
Journal:  Radiother Oncol       Date:  2006-05-11       Impact factor: 6.280

4.  Novel Radiobiological Gamma Index for Evaluation of 3-Dimensional Predicted Dose Distribution.

Authors:  Iori Sumida; Hajime Yamaguchi; Hisao Kizaki; Keiko Aboshi; Mari Tsujii; Nobuhiko Yoshikawa; Yuji Yamada; Osamu Suzuki; Yuji Seo; Fumiaki Isohashi; Yasuo Yoshioka; Kazuhiko Ogawa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-28       Impact factor: 7.038

5.  Per-beam, planar IMRT QA passing rates do not predict clinically relevant patient dose errors.

Authors:  Benjamin E Nelms; Heming Zhen; Wolfgang A Tomé
Journal:  Med Phys       Date:  2011-02       Impact factor: 4.071

Review 6.  Quantifying the position and steepness of radiation dose-response curves.

Authors:  S M Bentzen; S L Tucker
Journal:  Int J Radiat Biol       Date:  1997-05       Impact factor: 2.694

7.  Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method.

Authors:  G J Kutcher; C Burman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-06       Impact factor: 7.038

8.  Pretreatment patient-specific IMRT quality assurance: a correlation study between gamma index and patient clinical dose volume histogram.

Authors:  M Stasi; S Bresciani; A Miranti; A Maggio; V Sapino; P Gabriele
Journal:  Med Phys       Date:  2012-12       Impact factor: 4.071

9.  Improved models of tumour cure.

Authors:  S L Tucker; J M Taylor
Journal:  Int J Radiat Biol       Date:  1996-11       Impact factor: 2.694

10.  A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density.

Authors:  S Webb; A E Nahum
Journal:  Phys Med Biol       Date:  1993-06       Impact factor: 3.609

View more
  4 in total

1.  Impact of dose calculation models on radiotherapy outcomes and quality adjusted life years for lung cancer treatment: do we need to measure radiotherapy outcomes to tune the radiobiological parameters of a normal tissue complication probability model?

Authors:  Abdulhamid Chaikh; Nicolas Docquière; Pierre-Yves Bondiau; Jacques Balosso
Journal:  Transl Lung Cancer Res       Date:  2016-12

2.  Statistic and dosimetric criteria to assess the shift of the prescribed dose for lung radiotherapy plans when integrating point kernel models in medical physics: are we ready?

Authors:  Abdulhamid Chaikh; Jacques Balosso
Journal:  Transl Lung Cancer Res       Date:  2016-12

3.  Agreement between gamma passing rates using computed tomography in radiotherapy and secondary cancer risk prediction from more advanced dose calculated models.

Authors:  Abdulhamid Chaikh; Jacques Balosso
Journal:  Quant Imaging Med Surg       Date:  2017-06

4.  Evaluation and Performance of ArcCheck and Film using Gamma Criteria in Pre-treatment Quality Assurance of Stereotactic Ablative Radiotherapy.

Authors:  Prabhakar Ramachandran; Abdulrahman Tajaldeen; David Taylor; Derrick Wanigaratne; Karl Roozen; Moshi Geso
Journal:  J Med Phys       Date:  2017 Oct-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.